Hyperlipidemia: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 10: | Line 10: | ||
{{CMG}} | {{CMG}} | ||
==[[ | ==[[Hyperlipidemia overview|Overview]]== | ||
==[[ | ==[[Hyperlipidemia historical perspective|Historical Perspective]]== | ||
==[[ | ==[[Hyperlipidemia classification|Classification]]== | ||
[[Hyperlipidemiaclassification#Primary cardiac tumors|Primary cardiac tumors]] | [[Hyperlipidemiaclassification#Secondary cardiac tumors|Secondary cardiac tumors]] | [[Hyperlipidemiaclassification#Primary cardiac tumors|Primary cardiac tumors]] | [[Hyperlipidemiaclassification#Secondary cardiac tumors|Secondary cardiac tumors]] | ||
==[[ | ==[[Hyperlipidemia pathophysiology|Pathophysiology]]== | ||
==[[ | ==[[Hyperlipidemia causes|Causes]]== | ||
==[[ | ==[[Hyperlipidemia differential diagnosis|Differentiating Hyperlipidemiafrom other Diseases]]== | ||
==[[ | ==[[Hyperlipidemia epidemiology and demographics|Epidemiology and Demographics]]== | ||
==[[ | ==[[Hyperlipidemia risk factors|Risk factors]]== | ||
==[[ | ==[[Hyperlipidemia screening|Screening]]== | ||
==[[ | ==[[Hyperlipidemia natural history|Natural History, Complications and Prognosis]]== | ||
==Diagnosis== | ==Diagnosis== | ||
[[ | [[Hyperlipidemia history and symptoms|History and Symptoms]] | [[Hyperlipidemia physical examination|Physical Examination]] | [[Hyperlipidemia staging|Staging]] | [[Hyperlipidemia laboratory tests|Laboratory Findings]] | [[Hyperlipidemia electrocardiogram|Electrocardiogram]] | [[Hyperlipidemia chest x ray|Chest X Ray]] | [[Hyperlipidemia CT|CT]] | [[Hyperlipidemia MRI|MRI]] | [[Hyperlipidemia echocardiography or ultrasound|Echocardiography]] | [[Hyperlipidemia other imaging findings|Other Imaging Findings]] | [[Hyperlipidemia other diagnostic studies|Other Diagnostic Studies]] | ||
==Treatment== | ==Treatment== | ||
[[ | [[Hyperlipidemia medical therapy|Medical Therapy]] | [[Hyperlipidemia surgery|Surgery]] | [[Hyperlipidemia primary prevention|Primary Prevention]] | [[Hyperlipidemia secondary prevention|Secondary Prevention]] | ||
==Case Studies== | ==Case Studies== | ||
:[[ | :[[Hyperlipidemia case study one|Case #1]] | ||
---- | ---- | ||
==[[Hyperlipidemia overview | Overview]]== | ==[[Hyperlipidemia overview | Overview]]== | ||
Revision as of 14:44, 24 August 2012
For patient information click here Template:DiseaseDisorder infobox
|
Lipoprotein Disorders Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Primary cardiac tumors | Secondary cardiac tumors
Pathophysiology
Causes
Differentiating Hyperlipidemiafrom other Diseases
Epidemiology and Demographics
Risk factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Staging | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention
Case Studies
Overview
Risk factors
Screening
Screening tests | Screening frequency
Causes
Classification
Treatment
NCEP recommendations for children and adolescents with high-risk hyperlipidemia
Recommendations for drug therapy | Statins | Adjuvant therapies
Pharmacotherapy
Statins | Niacin | Fibrate | Omega-3 fatty acids
Trial supportive data
Niacin
AIM HIGH study
References
External links
| Hyperlipoproteinemia | OMIM | GPnotebook | WebMD | Others |
|---|---|---|---|---|
| Type I | Online Mendelian Inheritance in Man (OMIM) 238600 | Template:GPnotebook | . | MeritCare |
| Type IIa | Online Mendelian Inheritance in Man (OMIM) 144400 | Template:GPnotebook | . | Merck |
| Type IIb | Template:GPnotebook | . | ||
| Type III | . | Template:GPnotebook | WebMD | Yahoo |
| Type IV | Online Mendelian Inheritance in Man (OMIM) 144600 | Template:GPnotebook | WebMD | Yahoo |
| Type V | Online Mendelian Inheritance in Man (OMIM) 144600 | Template:GPnotebook | . | . |